BCL-2 isoform β promotes angiogenesis by TRiC-mediated upregulation of VEGF-A in lymphoma-Reference-Cited by-同舟云学术

BCL-2 isoform β promotes angiogenesis by TRiC-mediated upregulation of VEGF-A in lymphoma

Published:2022-06-14 Issue:28 Volume:41 Page:3655-3663
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Hang Xiaohang,Zhao Lei,Wu Baohong,Li Shujun,Liu Pengpeng,Xu Jing^ORCID,Wang Xinyuan,Chi Pengliang,Chen Chong^ORCID,Niu Ting,Dai Lunzhi^ORCID,Liu Yu^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-022-02372-0.pdf

Reference36 articles.

1. Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15:49–63.

2. Delbridge AR, Grabow S, Strasser A, Vaux DL. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer. 2016;16:99–109.

3. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984;226:1097–9.

4. Fukuhara S, Rowley JD. Chromosome 14 translocations in non-Burkitt lymphomas. Int J Cancer. 1978;22:14–21.

5. Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20:175–93.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovative genetic scissor strategies and their applications in cancer treatment and prevention: CRISPR modules and challenges;International Journal of Biological Macromolecules;2024-11

2. Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids;Frontiers in Oncology;2024-02-02

3. Nanocomposite fibers based on cellulose acetate loaded with fullerene for cancer therapy: preparation, characterization and in-vitro evaluation;Scientific Reports;2023-11-29

4. Notoginsenoside R1 can inhibit the interaction between FGF1 and VEGFA to retard podocyte apoptosis;BMC Endocrine Disorders;2023-07-06

5. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment;Bone Research;2023-02-27